Efficacy and Safety of Posiformin 2 % Eye Ointment in the Treatment of Blepharitis
Status:
Completed
Trial end date:
2009-08-01
Target enrollment:
Participant gender:
Summary
This is a multicentre, randomised, double-masked, parallel-group, phase IV comparison of
Posiformin 2 % eye ointment (active substance: bibrocathol) in the treatment of blepharitis.